Cancer Support Groups Need to Fit Their Audience

Article

Support Groups are a wonderful source of information and support, but the timing when a survivor joins can make all the difference.

As an avid proponent of support groups, I have to say that the first one I attended didn’t work. I didn’t know until much later that where we are in the journey can make a tremendous difference in a newly diagnosed person’s ability to take part.

Because I am an information junky, I sought out a group almost immediately after my diagnosis. Like most of the groups 30 years ago, this one was peer led. I have nothing against peer-led groups — that’s if someone has had some training in how to facilitate a group. We have all seen groups dominated by one person whose needs were probably massive before cancer ever entered the picture. Nothing can kill a support group quicker than one domineering person – and a trained facilitator (peer or professional) has the skills to redirect and mute these folks.

This peer facilitator of the first group I went to was fine. She was young — very young – and had breast cancer, although the group was open to all kinds of cancer.

The first night I went, I was scared about what I would find. I didn’t say much, which was very strange for me, and I know now that my only question for this group was an unspoken question.

Will I live?

In every moment, answer, question and movement, I was looking for reassurance that I would live.

The first night was easy, we talk about treatment and I got some advice. I don’t even remember exactly how many people were there or if I was the only new one. We met in the fellowship hall of a church. I was probably just struggling to keep from feeling the pain in the room.

The next meeting began with one of the group talking about recurrence — a place I knew was out there, but not one I wanted to visit.

It was also clear that something was different. Members were connected to each other in a way that was more intense than I knew. It was a connection I would find later with my support group. There was news in the room — news I didn’t know but could feel. About 10 minutes into the meeting, the leader from the last meeting arrived. Something was different. No longer a leader, she was clearly in need of leading. She began by saying that her scans came back positive and the cancer was back.

I was out of there. My body sat in the chair for the rest of the meeting, but my mind was gone. When the time was up, I headed for the door in a daze of “good wishes” and “see you later.”

No way. I didn’t want to go there yet.

When I went back to what would become my support group three years later, I formed the bond that I saw but didn’t understand in that first group. I also welcomed women who reminded me of myself that night — women who sat through the group, wearing the question we all knew so well: “Will I live?”

I would watch their faces when the understanding sank in that some of the women in the group had had recurrence. I’d watch them retreat into themselves and know that they wouldn’t be back next week and that there wasn’t anything I could do until they had traveled a little further on the journey.

It’s a problem with support groups that they almost need a mile marker outside the door to let women know where this group has been— and where it is going.

Sometimes the newbies won’t be able to tolerate the pain that is so evident in the room — the pain of loss and lives ended too soon. Just as the wrong support group is really awful, the right one can teach you and love you and give you peace.

I spent three years in the support group affiliated with my surgeon's office. These women became my sounding board to help me separate fact and fantasy. They let me cry when I was afraid and allowed me into their pain. I lived with them through our fear, and every other week we went to dinner together.

I haven’t seen any of them for years, but when I do run into one, we have a great time catching sound.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content